Prostate Cancer
First Participant Treated at the Highest Dose Level in Clarity’s Theranostic Prostate Cancer Trial
August 25, 2023
Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.
August 25, 2023
Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.
August 25, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration.
August 24, 2023
Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.
August 24, 2023
FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
August 23, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.
August 23, 2023
Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?
August 23, 2023